BCAL Diagnostics Limited (AU:BDX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BCAL Diagnostics Limited has announced the issuance of 9,150,000 performance rights as part of an employee incentive scheme. These securities are unquoted and intended for internal use to motivate and retain talent within the company. This move reflects BCAL’s commitment to aligning employee interests with corporate growth objectives.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.